Nash Duane

Number of records: 27
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
13-May-22 8:31 AM
View: 
Vital Therapies, Inc. (IMUX) 12-May-22Gift 6,000----(27%)
22.03K to 16.03K
13-May-22 8:31 AM
View: 
Vital Therapies, Inc. (IMUX) 12-May-22Private Purchase 10,000$5.03$50,300.0083%
12.03K to 22.03K
03-Jan-22 10:00 PM
View: 
Vital Therapies, Inc. (IMUX) 08-Nov-21Gift 3,000----(20%)
15.03K to 12.03K
11-Aug-21 9:02 AM
View: 
Vital Therapies, Inc. (IMUX) 10-Aug-21Market Purchase 1,000$9.80$9,800.007%
14.03K to 15.03K
(< 1%)
12-May-21 4:31 PM
View: 
Vital Therapies, Inc. (IMUX) 12-May-21Market Purchase 4,000$12.75$51,000.0040%
10.03K to 14.03K
8%
04-Dec-19 7:00 PM
View: 
Vital Therapies, Inc. (IMUX) 04-Dec-19Market Option Sale (Planned) 4,400$6.96$30,624.00(30%)
14.43K to 10.03K
(99%)
04-Dec-19 7:00 PM
View: 
Vital Therapies, Inc. (IMUX) 03-Dec-19Payment of Exercise 7,930$7.15$56,732.00(35%)
22.36K to 14.43K
(93%)
04-Dec-19 7:00 PM
View: 
Vital Therapies, Inc. (IMUX) 02-Dec-19Option Exercise 22,157----10808%
0.2K to 22.36K
16-Feb-18 4:07 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 15-Feb-18Market Sale (Planned) 1,000$14.62$14,620.00(4%)
22.5K to 21.5K
79%
04-Oct-17 4:21 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 02-Oct-17Market Sale (Planned) 1,188$19.64$23,332.30(5%)
23.69K to 22.5K
85%
06-Jul-17 12:23 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 03-Jul-17Market Sale (Planned) 990$14.27$14,127.30(4%)
24.68K to 23.69K
79%
09-Jun-17 4:06 PM
View: 
Vital Therapies, Inc. (IMUX) 08-Jun-17Market Purchase 3,900$3.12$12,182.0090%
4.32K to 8.22K
(87%)
04-Apr-17 4:01 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 03-Apr-17Market Sale (Planned) 991$9.20$9,119.28(4%)
25.67K to 24.68K
67%
03-Jan-17 4:02 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 03-Jan-17Market Sale (Planned) 1,980$10.46$20,711.00(7%)
27.65K to 25.67K
71%
17-Jan-17 10:00 PM
View: 
Vital Therapies, Inc. (IMUX) 23-Dec-16Gift 5,000----(54%)
9.32K to 4.32K
04-Oct-16 4:12 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 03-Oct-16Market Sale (Planned) 1,981$8.96$17,746.00(7%)
29.63K to 27.65K
68%
07-Jul-16 4:07 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 06-Jul-16Market Sale (Planned) 1,980$7.48$14,818.50(6%)
31.61K to 29.63K
62%
05-Oct-15 4:06 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 02-Oct-15Market Sale (Planned) 996$8.65$8,617.29(3%)
32.6K to 31.61K
67%
06-Jul-15 4:04 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 02-Jul-15Market Sale (Planned) 996$9.53$9,489.89(3%)
33.6K to 32.6K
70%
06-Apr-15 4:14 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 02-Apr-15Market Sale (Planned) 996$9.09$9,051.75(8%)
13.01K to 12.02K
69%
06-Apr-15 4:14 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Apr-15Grant 1,980$9.51$18,829.8018%
11.03K to 13.01K
(70%)
05-Jan-15 4:32 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 02-Jan-15Market Sale (Planned) 995$11.46$11,403.40(7%)
13.81K to 12.81K
75%
05-Jan-15 4:32 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Jan-15Grant 1,980$11.64$23,047.2017%
11.83K to 13.81K
(76%)
29-Dec-14 4:25 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 26-Dec-14Market Sale (Planned) 5,169$11.19$57,845.80(30%)
17.0K to 11.83K
75%
29-Dec-14 4:25 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 24-Dec-14Market Sale (Planned) 6,764$11.26$76,189.00(28%)
23.76K to 17.0K
75%
29-Dec-14 4:25 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 23-Dec-14Grant 23,762$11.54$274,213.00100%
0 to 23.76K
(75%)
09-Oct-14 9:09 PM
View: 
Vital Therapies, Inc. (IMUX) 08-Oct-14Market Purchase 100$17.50$1,750.001%
9.22K to 9.32K
(98%)